TCM and its active ingredients with great anti-tumor activity augment the efficacy of EGFR-TKIs in NSCLC (Chen and Feng 2021; Sui et al. 2020; Tang et al. 2019; Yao et al. 2020). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.